Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

Preventive Antiepileptic Treatment in Tuberous Sclerosis Complex: Long-Term, Prospective Trial.

Jozwiak S, Słowińska M, Borkowska J, Sadowski K, Łojszczyk B, Domańska-Pakieła D, Chmielewski D, Kaczorowska-Frontczak M, Głowacka J, Sijko K, Kotulska K.

Pediatr Neurol. 2019 Jul 23. pii: S0887-8994(19)30601-0. doi: 10.1016/j.pediatrneurol.2019.07.008. [Epub ahead of print]

PMID:
31481332
2.

Germinoma Mimicking Brain Inflammation: A Case Report.

Pierzchlewicz K, Bilska M, Jurkiewicz E, Chmielewski D, Moszczyńska E, Daszkiewicz P, Ciołkowski M, Grajkowska W, Kotulska K.

Child Neurol Open. 2019 May 20;6:2329048X19848181. doi: 10.1177/2329048X19848181. eCollection 2019.

3.

Early Clinical Predictors of Autism Spectrum Disorder in Infants with Tuberous Sclerosis Complex: Results from the EPISTOP Study.

Moavero R, Benvenuto A, Emberti Gialloreti L, Siracusano M, Kotulska K, Weschke B, Riney K, Jansen FE, Feucht M, Krsek P, Nabbout R, Jansen AC, Wojdan K, Borkowska J, Sadowski K, Hertzberg C, Hulshof H, Samueli S, Benova B, Aronica E, Kwiatkowski DJ, Lagae L, Jozwiak S, Curatolo P.

J Clin Med. 2019 Jun 3;8(6). pii: E788. doi: 10.3390/jcm8060788.

4.

Problems of nephrooncology. Proceedings from the 1st Scientific and Training Conference Nephrooncology 5-6 October 2018, Gdańsk, Poland.

Bączkowska T, Bissler JJ, Błasińska‑Przerwa K, Borawski J, Chudek J, Ciechanowski K, Czarkowska‑Pączek B, Dębska-Ślizień A, Domański M, Durlik M, Gellert R, Gozdowska J, Goździk M, Imko‑Walczuk B, Janiszewski J, Januszko‑Giergielewicz B, Jeśkiewicz M, Jóźwiak S, Kadylak D, Klinger M, Kosieradzki M, Kotulska K, Kozak Ł, Król E, Krzanowska K, Kurnatowska I, Labij‑Reduta B, Lichodziejewska‑Niemierko M, Lizakowski S, Małyszko J, Matuszewski M, Mazurkiewicz J, Mełeń‑Mucha G, Myślak M, Naumnik B, Nowicki M, Oko A, Pączek L, Perkowska-Ptasińska A, Piątak M, Piecha G, Radzikowska E, Renke M, Rutkowska B, Sawosz M, Skutecki R, Słowińska M, Sosińska‑Mielcarek K, Szafran‑Dobrowolska J, Szołkowska M, Szczepulska‑Wójcik E, Szurowska E, Tarasewicz A, Wągrowska‑Danilewicz M, Wołowiec D, Woźniak J, Zawiasa‑Bryszewska A.

Pol Arch Intern Med. 2019 May 2;129(Spec. Issue 2):1-74. doi: 10.20452/pamw.14821. Epub 2019 May 2. No abstract available.

5.

GSK3β activity alleviates epileptogenesis and limits GluA1 phosphorylation.

Urbanska M, Kazmierska-Grebowska P, Kowalczyk T, Caban B, Nader K, Pijet B, Kalita K, Gozdz A, Devijver H, Lechat B, Jaworski T, Grajkowska W, Sadowski K, Jozwiak S, Kotulska K, Konopacki J, Van Leuven F, van Vliet EA, Aronica E, Jaworski J.

EBioMedicine. 2019 Jan;39:377-387. doi: 10.1016/j.ebiom.2018.11.040. Epub 2018 Nov 28.

6.

The level of microRNA 21 is upregulated by rapamycin in serum of tuberous sclerosis complex patients and subependymal giant cell astrocytoma (SEGA)-derived cell cultures.

Kuzniewska B, Sadowski K, Urbanska K, Urbanska M, Kotulska K, Liszewska E, Grajkowska W, Jóźwiak S, Dziembowska M.

Folia Neuropathol. 2018;56(3):167-174. doi: 10.5114/fn.2018.78695.

7.

MicroRNA519d and microRNA4758 can identify gangliogliomas from dysembryoplastic neuroepithelial tumours and astrocytomas.

Bongaarts A, Prabowo AS, Arena A, Anink JJ, Reinten RJ, Jansen FE, Spliet WGM, Thom M, Coras R, Blümcke I, Kotulska K, Jozwiak S, Grajkowska W, Söylemezoğlu F, Pimentel J, Schouten-van Meeteren AYN, Mills JD, Iyer AM, van Vliet EA, Mühlebner A, Aronica E.

Oncotarget. 2018 Jun 15;9(46):28103-28115. doi: 10.18632/oncotarget.25563. eCollection 2018 Jun 15.

8.

Management of epilepsy associated with tuberous sclerosis complex: Updated clinical recommendations.

Curatolo P, Nabbout R, Lagae L, Aronica E, Ferreira JC, Feucht M, Hertzberg C, Jansen AC, Jansen F, Kotulska K, Moavero R, O'Callaghan F, Papavasiliou A, Tzadok M, Jóźwiak S.

Eur J Paediatr Neurol. 2018 Sep;22(5):738-748. doi: 10.1016/j.ejpn.2018.05.006. Epub 2018 May 24. Review.

PMID:
29880258
9.

Liver Angiomyolipomas in Tuberous Sclerosis Complex-Their Incidence and Course.

Jóźwiak S, Sadowski K, Borkowska J, Domańska-Pakieła D, Chmielewski D, Jurkiewicz E, Jaworski M, Urbańska M, Ogrodnik M, Słowińska M, Kotulska K.

Pediatr Neurol. 2018 Jan;78:20-26. doi: 10.1016/j.pediatrneurol.2017.09.012. Epub 2017 Sep 28.

PMID:
29249553
10.

Subependymal giant cell astrocytomas in Tuberous Sclerosis Complex have consistent TSC1/TSC2 biallelic inactivation, and no BRAF mutations.

Bongaarts A, Giannikou K, Reinten RJ, Anink JJ, Mills JD, Jansen FE, Spliet GMW, den Dunnen WFA, Coras R, Blümcke I, Paulus W, Scholl T, Feucht M, Kotulska K, Jozwiak S, Buccoliero AM, Caporalini C, Giordano F, Genitori L, Söylemezoğlu F, Pimentel J, Nellist M, Schouten-van Meeteren AYN, Nag A, Mühlebner A, Kwiatkowski DJ, Aronica E.

Oncotarget. 2017 Sep 8;8(56):95516-95529. doi: 10.18632/oncotarget.20764. eCollection 2017 Nov 10.

11.

Papillary thyroid carcinoma in a boy with familial tuberous sclerosis complex attributable to a TSC2 deletion-a case report.

Flader M, Kurzawa P, Maldyk J, Sygut J, Harasymczuk J, Kropinska A, Handkiewicz-Junak D, Jarzab B, Kotulska K, Niedziela M.

Curr Oncol. 2017 Oct;24(5):e423-e428. doi: 10.3747/co.24.3555. Epub 2017 Oct 25.

12.

Coding and small non-coding transcriptional landscape of tuberous sclerosis complex cortical tubers: implications for pathophysiology and treatment.

Mills JD, Iyer AM, van Scheppingen J, Bongaarts A, Anink JJ, Janssen B, Zimmer TS, Spliet WG, van Rijen PC, Jansen FE, Feucht M, Hainfellner JA, Krsek P, Zamecnik J, Kotulska K, Jozwiak S, Jansen A, Lagae L, Curatolo P, Kwiatkowski DJ, Pasterkamp RJ, Senthilkumar K, von Oerthel L, Hoekman MF, Gorter JA, Crino PB, Mühlebner A, Scicluna BP, Aronica E.

Sci Rep. 2017 Aug 14;7(1):8089. doi: 10.1038/s41598-017-06145-8.

13.

What are the true volumes of SEGA tumors? Reliability of planimetric and popular semi-automated image segmentation methods.

Stawiski K, Trelińska J, Baranska D, Dachowska I, Kotulska K, Jóźwiak S, Fendler W, Młynarski W.

MAGMA. 2017 Aug;30(4):397-405. doi: 10.1007/s10334-017-0614-3. Epub 2017 Mar 20.

PMID:
28321524
14.

Molecular neurobiology of mTOR.

Switon K, Kotulska K, Janusz-Kaminska A, Zmorzynska J, Jaworski J.

Neuroscience. 2017 Jan 26;341:112-153. doi: 10.1016/j.neuroscience.2016.11.017. Epub 2016 Nov 23. Review.

15.

Maintenance therapy with everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis (the EMINENTS study).

Trelinska J, Dachowska I, Baranska D, Stawiski K, Kotulska K, Fendler W, Jozwiak S, Mlynarski W.

Pediatr Blood Cancer. 2017 Jun;64(6). doi: 10.1002/pbc.26347. Epub 2016 Nov 15.

PMID:
27860334
16.

Tuberous sclerosis complex: From molecular biology to novel therapeutic approaches.

Switon K, Kotulska K, Janusz-Kaminska A, Zmorzynska J, Jaworski J.

IUBMB Life. 2016 Dec;68(12):955-962. doi: 10.1002/iub.1579. Epub 2016 Oct 31. Review.

17.

Abnormal serum microRNA profiles in tuberous sclerosis are normalized during treatment with everolimus: possible clinical implications.

Trelinska J, Fendler W, Dachowska I, Kotulska K, Jozwiak S, Antosik K, Gnys P, Borowiec M, Mlynarski W.

Orphanet J Rare Dis. 2016 Sep 29;11(1):129.

18.

Everolimus treatment among patients with tuberous sclerosis affects serum lipid profile.

Trelińska J, Dachowska I, Kotulska K, Jóźwiak S, Fendler W, Młynarski W.

Pharmacol Rep. 2016 Oct;68(5):1002-7. doi: 10.1016/j.pharep.2016.05.011. Epub 2016 Jul 17.

PMID:
27423526
19.

Topical Use of Mammalian Target of Rapamycin (mTOR) Inhibitors in Tuberous Sclerosis Complex-A Comprehensive Review of the Literature.

Jóźwiak S, Sadowski K, Kotulska K, Schwartz RA.

Pediatr Neurol. 2016 Aug;61:21-7. doi: 10.1016/j.pediatrneurol.2016.04.003. Epub 2016 Apr 13. Review.

PMID:
27222056
20.

Expression of microRNAs miR21, miR146a, and miR155 in tuberous sclerosis complex cortical tubers and their regulation in human astrocytes and SEGA-derived cell cultures.

van Scheppingen J, Iyer AM, Prabowo AS, Mühlebner A, Anink JJ, Scholl T, Feucht M, Jansen FE, Spliet WG, Krsek P, Zamecnik J, Buccoliero AM, Giordano F, Genitori L, Kotulska K, Jozwiak S, Jaworski J, Liszewska E, van Vliet EA, Aronica E.

Glia. 2016 Jun;64(6):1066-82. doi: 10.1002/glia.22983. Epub 2016 Mar 25.

PMID:
27014996
21.

The Role of mTOR Inhibitors in the Treatment of Patients with Tuberous Sclerosis Complex: Evidence-based and Expert Opinions.

Curatolo P, Bjørnvold M, Dill PE, Ferreira JC, Feucht M, Hertzberg C, Jansen A, Jóźwiak S, Kingswood JC, Kotulska K, Macaya A, Moavero R, Nabbout R, Zonnenberg BA.

Drugs. 2016 Apr;76(5):551-65. doi: 10.1007/s40265-016-0552-9. Review.

PMID:
26927950
22.

Long-term High Fat Ketogenic Diet Promotes Renal Tumor Growth in a Rat Model of Tuberous Sclerosis.

Liśkiewicz AD, Kasprowska D, Wojakowska A, Polański K, Lewin-Kowalik J, Kotulska K, Jędrzejowska-Szypułka H.

Sci Rep. 2016 Feb 19;6:21807. doi: 10.1038/srep21807.

23.

Management of side effects of mTOR inhibitors in tuberous sclerosis patients.

Sadowski K, Kotulska K, Jóźwiak S.

Pharmacol Rep. 2016 Jun;68(3):536-42. doi: 10.1016/j.pharep.2016.01.005. Epub 2016 Jan 22. Review.

PMID:
26891243
24.

Safety of Everolimus in Patients Younger than 3 Years of Age: Results from EXIST-1, a Randomized, Controlled Clinical Trial.

Jóźwiak S, Kotulska K, Berkowitz N, Brechenmacher T, Franz DN.

J Pediatr. 2016 May;172:151-155.e1. doi: 10.1016/j.jpeds.2016.01.027. Epub 2016 Feb 6.

PMID:
26858193
25.

Early onset epileptic encephalopathy or genetically determined encephalopathy with early onset epilepsy? Lessons learned from TSC.

Curatolo P, Aronica E, Jansen A, Jansen F, Kotulska K, Lagae L, Moavero R, Jozwiak S.

Eur J Paediatr Neurol. 2016 Mar;20(2):203-211. doi: 10.1016/j.ejpn.2015.12.005. Epub 2015 Dec 23. Review.

PMID:
26758984
26.

Age and Gender-Related Changes in Biogenic Amine Metabolites in Cerebrospinal Fluid in Children.

Kuśmierska K, Szymańska K, Rokicki D, Kotulska K, Jóźwiak S, Sykut-Cegielska J, Mierzewska H, Szczepanik E, Pronicka E, Demkow U.

Adv Exp Med Biol. 2016;878:73-82.

PMID:
26453071
27.

Down-regulation of IKKβ expression in glioma-infiltrating microglia/macrophages is associated with defective inflammatory/immune gene responses in glioblastoma.

Mieczkowski J, Kocyk M, Nauman P, Gabrusiewicz K, Sielska M, Przanowski P, Maleszewska M, Rajan WD, Pszczolkowska D, Tykocki T, Grajkowska W, Kotulska K, Roszkowski M, Kostkiewicz B, Kaminska B.

Oncotarget. 2015 Oct 20;6(32):33077-90. doi: 10.18632/oncotarget.5310.

28.

Systemic effects of treatment with mTOR inhibitors in tuberous sclerosis complex: a comprehensive review.

Sadowski K, Kotulska K, Schwartz RA, Jóźwiak S.

J Eur Acad Dermatol Venereol. 2016 Apr;30(4):586-94. doi: 10.1111/jdv.13356. Epub 2015 Sep 25. Review.

PMID:
26403211
29.

Tuberous sclerosis complex neuropathology requires glutamate-cysteine ligase.

Malik AR, Liszewska E, Skalecka A, Urbanska M, Iyer AM, Swiech LJ, Perycz M, Parobczak K, Pietruszka P, Zarebska MM, Macias M, Kotulska K, Borkowska J, Grajkowska W, Tyburczy ME, Jozwiak S, Kwiatkowski DJ, Aronica E, Jaworski J.

Acta Neuropathol Commun. 2015 Jul 30;3:48. doi: 10.1186/s40478-015-0225-z.

30.

Severe central and peripheral paraneoplastic demyelination associated with tumours of the ovaries.

Jurkiewicz E, Kotulska K, Nowak K, Malczyk K, Borkowska J, Bilska M.

Childs Nerv Syst. 2015 Sep;31(9):1601-6. doi: 10.1007/s00381-015-2731-5. Epub 2015 May 13.

31.

Complications of mammalian target of rapamycin inhibitor anticancer treatment among patients with tuberous sclerosis complex are common and occasionally life-threatening.

Trelinska J, Dachowska I, Kotulska K, Fendler W, Jozwiak S, Mlynarski W.

Anticancer Drugs. 2015 Apr;26(4):437-42. doi: 10.1097/CAD.0000000000000207.

PMID:
25719621
32.

Factors affecting response to everolimus therapy for subependymal giant cell astrocytomas associated with tuberous sclerosis.

Trelinska J, Dachowska I, Kotulska K, Baranska D, Fendler W, Jozwiak S, Mlynarski W.

Pediatr Blood Cancer. 2015 Apr;62(4):616-21. doi: 10.1002/pbc.25368. Epub 2015 Jan 3.

PMID:
25557360
33.

A shower of second hit events as the cause of multifocal renal cell carcinoma in tuberous sclerosis complex.

Tyburczy ME, Jozwiak S, Malinowska IA, Chekaluk Y, Pugh TJ, Wu CL, Nussbaum RL, Seepo S, Dzik T, Kotulska K, Kwiatkowski DJ.

Hum Mol Genet. 2015 Apr 1;24(7):1836-42. doi: 10.1093/hmg/ddu597. Epub 2014 Nov 28.

34.

Prevention of epileptogenesis--a new goal for epilepsy therapy.

Jóźwiak S, Kotulska K.

Pediatr Neurol. 2014 Dec;51(6):758-9. doi: 10.1016/j.pediatrneurol.2014.08.019. Epub 2014 Sep 4. Review. No abstract available.

35.

Congenital subependymal giant cell astrocytomas in patients with tuberous sclerosis complex.

Kotulska K, Borkowska J, Mandera M, Roszkowski M, Jurkiewicz E, Grajkowska W, Bilska M, Jóźwiak S.

Childs Nerv Syst. 2014 Dec;30(12):2037-42. doi: 10.1007/s00381-014-2555-8. Epub 2014 Sep 17.

36.

Epilepsy in newborns with tuberous sclerosis complex.

Kotulska K, Jurkiewicz E, Domańska-Pakieła D, Grajkowska W, Mandera M, Borkowska J, Jóźwiak S.

Eur J Paediatr Neurol. 2014 Nov;18(6):714-21. doi: 10.1016/j.ejpn.2014.06.009. Epub 2014 Jul 5.

PMID:
25030328
37.

Surgical treatment of subependymal giant cell astrocytoma in tuberous sclerosis complex patients.

Kotulska K, Borkowska J, Roszkowski M, Mandera M, Daszkiewicz P, Drabik K, Jurkiewicz E, Larysz-Brysz M, Nowak K, Grajkowska W, Domańska-Pakieła D, Jóźwiak S.

Pediatr Neurol. 2014 Apr;50(4):307-12. doi: 10.1016/j.pediatrneurol.2013.12.004. Epub 2013 Dec 10.

PMID:
24507694
38.

EEG abnormalities preceding the epilepsy onset in tuberous sclerosis complex patients - a prospective study of 5 patients.

Domańska-Pakieła D, Kaczorowska M, Jurkiewicz E, Kotulska K, Dunin-Wąsowicz D, Jóźwiak S.

Eur J Paediatr Neurol. 2014 Jul;18(4):458-68. doi: 10.1016/j.ejpn.2013.12.006. Epub 2013 Dec 31.

PMID:
24412076
39.

MR venography in children and adolescents with multiple sclerosis does not show increased prevalence of extracranial veins anomalies.

Jurkiewicz E, Kotulska K, Nowak K, Chełstowska S, Armata M, Chmielewski D, Bilska M.

Eur J Paediatr Neurol. 2014 Mar;18(2):218-22. doi: 10.1016/j.ejpn.2013.11.013. Epub 2013 Dec 25.

PMID:
24411179
40.

"Drop attacks" as first clinical symptoms in a child carrying MTTK m.8344A>G mutation.

Buda P, Piekutowska-Abramczuk D, Karkucińska-Więckowska A, Jurkiewicz E, Chełstowska S, Pajdowska M, Migdał M, Książyk J, Kotulska K, Pronicka E.

Folia Neuropathol. 2013;51(4):347-54.

41.

Possible prevention of tuberous sclerosis complex lesions.

Kotulska K, Borkowska J, Jozwiak S.

Pediatrics. 2013 Jul;132(1):e239-42. doi: 10.1542/peds.2012-3607. Epub 2013 Jun 3.

PMID:
23733802
42.

Long-term effect of everolimus on epilepsy and growth in children under 3 years of age treated for subependymal giant cell astrocytoma associated with tuberous sclerosis complex.

Kotulska K, Chmielewski D, Borkowska J, Jurkiewicz E, Kuczyński D, Kmieć T, Łojszczyk B, Dunin-Wąsowicz D, Jóźwiak S.

Eur J Paediatr Neurol. 2013 Sep;17(5):479-85. doi: 10.1016/j.ejpn.2013.03.002. Epub 2013 Apr 6.

PMID:
23567018
43.

Distinct roles of CSF family cytokines in macrophage infiltration and activation in glioma progression and injury response.

Sielska M, Przanowski P, Wylot B, Gabrusiewicz K, Maleszewska M, Kijewska M, Zawadzka M, Kucharska J, Vinnakota K, Kettenmann H, Kotulska K, Grajkowska W, Kaminska B.

J Pathol. 2013 Jul;230(3):310-21. doi: 10.1002/path.4192.

PMID:
23520016
44.

Everolimus (RAD001): first systemic treatment for subependymal giant cell astrocytoma associated with tuberous sclerosis complex.

Józwiak S, Stein K, Kotulska K.

Future Oncol. 2012 Dec;8(12):1515-23. doi: 10.2217/fon.12.146. Review.

PMID:
23231513
45.

Air gun impactor--a novel model of graded white matter spinal cord injury in rodents.

Marcol W, Slusarczyk W, Gzik M, Larysz-Brysz M, Bobrowski M, Grynkiewicz-Bylina B, Rosicka P, Kalita K, Węglarz W, Barski JJ, Kotulska K, Labuzek K, Lewin-Kowalik J.

J Reconstr Microsurg. 2012 Oct;28(8):561-8. doi: 10.1055/s-0032-1315779. Epub 2012 Jun 18.

PMID:
22711195
46.

Interleukin-1β increases release of endothelin-1 and tumor necrosis factor as well as reactive oxygen species by peripheral leukocytes during experimental subarachnoid hemorrhage.

Larysz-Brysz M, Lewin-Kowalik J, Czuba Z, Kotulska K, Olakowska E, Marcol W, Liśkiewicz A, Jędrzejowska-Szypułka H.

Curr Neurovasc Res. 2012 Aug;9(3):159-66.

PMID:
22621234
47.

Is it time to use preventative antiepileptic drug in TSC?

Jozwiak S, Kotulska K.

Epilepsy Behav. 2012 Mar;23(3):393. doi: 10.1016/j.yebeh.2011.12.024. Epub 2012 Feb 17. No abstract available.

PMID:
22342436
48.

Reduction of post-traumatic neuroma and epineural scar formation in rat sciatic nerve by application of microcrystallic chitosan.

Marcol W, Larysz-Brysz M, Kucharska M, Niekraszewicz A, Slusarczyk W, Kotulska K, Wlaszczuk P, Wlaszczuk A, Jedrzejowska-Szypulka H, Lewin-Kowalik J.

Microsurgery. 2011 Nov;31(8):642-9. doi: 10.1002/micr.20945. Epub 2011 Oct 18.

PMID:
22009638
49.

Effective everolimus treatment of inoperable, life-threatening subependymal giant cell astrocytoma and intractable epilepsy in a patient with tuberous sclerosis complex.

Perek-Polnik M, Jóźwiak S, Jurkiewicz E, Perek D, Kotulska K.

Eur J Paediatr Neurol. 2012 Jan;16(1):83-5. doi: 10.1016/j.ejpn.2011.09.006. Epub 2011 Oct 13.

PMID:
22000822
50.

APP/SOD1 overexpressing mice present reduced neuropathic pain sensitivity.

Kotulska K, Larysz-Brysz M, LePecheur M, Marcol W, Olakowska E, Lewin-Kowalik J, London J.

Brain Res Bull. 2011 Jul 15;85(6):321-8. doi: 10.1016/j.brainresbull.2011.05.006. Epub 2011 May 13.

PMID:
21605634

Supplemental Content

Loading ...
Support Center